JG
RYTM icon

Jain Global’s Rhythm Pharmaceuticals RYTM Stock Holding History

Jain Global’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-35,110
Closed -$3.55M – 1476
2025
Q3 		$3.55M Buy
35,110
+31,202
+798% +$2.9M 0.02% 427
2025
Q2 		$247K Buy
+3,908
New +$239K ﹤0.01% 933
2025
Q1 		– Sell
-6,700
Closed -$375K – 1309
2024
Q4 		$375K Buy
+6,700
New +$370K 0.01% 515

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jain Global's RYTM Position: Q4 2025 in Review

Jain Global sold out of Rhythm Pharmaceuticals (RYTM) in Q4 2025, closing a stake of 35,110 shares — an estimated $3.55M sold.

Jain Global first reported a position in RYTM in Q4 2024 and held it in 3 quarters. The position peaked at $3.55M in Q3 2025. 279 funds tracked by Wall St. Rank hold RYTM as of Q4 2025.

  • Jain Global reported no remaining Rhythm Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Jain Global sold 35,110 Rhythm Pharmaceuticals shares in Q4 2025, an estimated $3.55M.
  • Jain Global first reported a position in Rhythm Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • Jain Global's Rhythm Pharmaceuticals position peaked at $3.55M in Q3 2025.
  • 279 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q4 2025.

Based on Jain Global's 13F filing for Q4 2025, filed 17 Feb 2026.